fluorodeoxyglucose f18 has been researched along with Signet Ring Cell Carcinoma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 5 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, YH; Yang, MF | 1 |
| Güzel, Y; Kaplan, İ; Kepenek, F; Kömek, H; Söğütçü, N | 1 |
| Cho, YS; Chung, IK; Lee, JW; Lee, MS; Lee, SM; Son, MW | 1 |
| Guo, H; Li, W; Meng, Z; Zhou, H | 1 |
| González, E; Martí, A; Morón, S; Rojas, J | 1 |
| Dwyer, JP; Khan, SA; Vaughan, R | 1 |
| González, J; González, P; Hiplan, E; Humeres, P; Prado, E | 1 |
| Carter, BW; Goense, L; Ho, L; Hofstetter, WL; Lin, SH; Maru, DM; Meijer, GJ; van Hillegersberg, R; van Rossum, PSN; Xi, M | 1 |
| Basher, RK; Mittal, BR; Parihar, AS; Singh, G; Sood, A | 1 |
| Heegaard, S; Prause, JU; Pryds, A; Toft, PB; Venzo, A | 1 |
| Baba, H; Baba, Y; Ida, S; Ishimoto, T; Iwagami, S; Iwatsuki, M; Miyamoto, Y; Nagai, Y; Sakamoto, Y; Watanabe, M; Yamao, T | 1 |
| Duong, C; Hicks, RJ; Kaneko, Y; Link, E; Murray, WK | 1 |
| Chen, R; Huang, G; Liu, J; Zhou, X | 1 |
| Chikuta, I; Edo, N; Ishikawa, T; Mashimo, Y; Masugi, H; Morita, K; Ota, S; Sakamoto, T; Seki, N; Tokairin, T | 1 |
| Cheong, JH; Choi, SH; Hyung, WJ; Noh, SH; Pak, KH; Yun, M | 1 |
| Adler, LP; Buyyounouski, MK; Klump, WJ; Konski, A; Wu, H | 1 |
| Chen, J; Cheong, JH; Hyung, WJ; Kim, J; Lim, JS; Noh, SH; Yun, MJ | 1 |
| Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
| Bhure, U; Hany, TF; Pestalozzi, BC; Schmitt, AM; Strobel, K | 1 |
| Bormans, G; De Potter, T; Filez, L; Flamen, P; Maes, A; Mortelmans, L; Penninckx, F; Van Cutsem, E | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Observer Variation; Patient Selection; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2015 |
19 other study(ies) available for fluorodeoxyglucose f18 and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Comparison of 18F-AlF-NOTA-FAPI and 18F-FDG Imaging in a Patient With Gastric Signet-Ring Cell Carcinoma.
Topics: Carcinoma, Signet Ring Cell; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Perirenal Infiltration of Signet Ring Cell Colon Carcinoma Shown by 68Ga-FAPI PET/CT.
Topics: Carcinoma, Signet Ring Cell; Colon; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2020 |
Primary hepatic squamous carcinoma concurrent with gastric signet ring cell carcinoma demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia
Topics: Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Carcinoma, Signet Ring Cell; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pleural Effusion; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Seminoma; Stomach Neoplasms | 2020 |
Peritoneal carcinomatosis from signet-ring cell adenocarcinoma of the appendix.
Topics: Appendiceal Neoplasms; Carcinoma, Signet Ring Cell; Colonoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
[Bone metastases of a gallbladder carcinoma detected by positron emission tomography/computed tomography: Case report].
Topics: Aged; Bone Neoplasms; Carcinoma, Signet Ring Cell; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Nomograms; Oxaliplatin; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Radiotherapy Dosage; Risk Assessment; Sex Factors; Survival Rate | 2018 |
68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Signet Ring Cell; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
Sentinel node biopsy and frozen section procedure in signet ring cell carcinoma of the eyelid and orbit.
Topics: Aged; Carcinoma, Signet Ring Cell; Eyelid Neoplasms; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Sodium Pertechnetate Tc 99m | 2014 |
False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Neoplasms; Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; False Positive Reactions; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2014 |
Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Young Adult | 2016 |
Ultrasound findings of diffuse metastasis of gastric signet-ring-cell carcinoma to the thyroid gland.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Signet Ring Cell; Diagnosis, Differential; Endoscopy, Gastrointestinal; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Ultrasonography, Doppler, Color | 2017 |
Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2011 |
FDG PET imaging of signet-ring cell adenocarcinoma of the stomach.
Topics: Adult; Carcinoma, Signet Ring Cell; Feeding and Eating Disorders; Fluorodeoxyglucose F18; Humans; Male; Nausea; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2005 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
FDG-negative signet ring cell cancer of the stomach with FDG-positive skin metastases.
Topics: Adult; Carcinoma, Signet Ring Cell; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms | 2007 |
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Carcinoma, Signet Ring Cell; Databases, Factual; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |